Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)
Status:
Recruiting
Trial end date:
2031-11-01
Target enrollment:
Participant gender:
Summary
The VILT-502 study is Non-interventional Study(United States)/Low-intervention Clinical Trial
(Canada) of Viltolarsen administered intravenously once weekly for 10 years to boys with DMD
who complete the NS-065/NCNP-01-202 study.